Literature DB >> 12874462

Cholesterol and the risk of renal dysfunction in apparently healthy men.

Elke S Schaeffner1,1,1, Tobias Kurth1,1,1, Gary C Curhan1,1, Robert J Glynn1,1, Kathryn M Rexrode1, Colin Baigent1, Julie E Buring1,1,1, J Michael Gaziano1,1,1,1.   

Abstract

Despite extensive knowledge about abnormal lipid patterns in patients with end-stage renal disease, the association between cholesterol and the development of renal dysfunction is unclear. We evaluated this association in a prospective cohort study among 4,483 initially healthy men participating in the Physicians' Health Study who provided blood samples in 1982 and 1996. Main outcome measures were elevated creatinine, defined as >/= 1.5 mg/dl (133 micromol/L), and reduced estimated creatinine clearance, defined as </=55 ml/min. Cholesterol parameters included total cholesterol (<200, 200 to 239, and >/= 240 mg/dl), HDL (<40 or >/= 40 mg/dl), total non-HDL cholesterol, and the ratio of total cholesterol to HDL. We used logistic regression to calculate age- and multivariable adjusted odds ratios as a measure for the relative risk. After 14 yr, 134 men (3.0%) had elevated creatinine and 244 (5.4%) had reduced creatinine clearance. The multivariable relative risk for elevated creatinine was 1.77 (95% confidence interval [CI], 1.10 to 2.86) for total cholesterol >/= 240 mg/dl, 2.16 (95% CI, 1.42 to 3.27) for HDL <40 mg/dl, 2.34 (95% CI, 1.34 to 4.07) for the highest quartile of total cholesterol/HDL ratio (>/= >6.8), and 2.16 (95% CI, 1.22 to 3.80) for the highest quartile of non-HDL cholesterol (>/= 196.1). Similar although smaller associations were observed between cholesterol parameters and reduced creatinine clearance. Elevated total cholesterol, high non-HDL cholesterol, a high ratio of total cholesterol/HDL, and low HDL in particular were significantly associated with an increased risk of developing renal dysfunction in men with an initial creatinine <1.5 mg/dl.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874462     DOI: 10.1681/ASN.V1482084

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  117 in total

1.  The incidence of low eGFR and proteinuria in a large tertiary referral lipid clinic.

Authors:  Joseph B Davies; Martin A Crook; Anthony S Wierzbicki; David J Goldsmith
Journal:  Int Urol Nephrol       Date:  2010-08-13       Impact factor: 2.370

Review 2.  HMG-CoA reductase inhibitors and the kidney.

Authors:  Vito M Campese; Bassel Hadaya; Josephine Chiu
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

3.  Applying the Temporal Abstraction Technique to the Prediction of Chronic Kidney Disease Progression.

Authors:  Li-Chen Cheng; Ya-Han Hu; Shr-Han Chiou
Journal:  J Med Syst       Date:  2017-04-11       Impact factor: 4.460

4.  Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: a single-center, cross-sectional study.

Authors:  Masahiko Yazawa; Ryo Kido; Yugo Shibagaki; Takashi Yasuda; Ryuto Nakazawa; Hideo Sasaki; Yuichi Sato; Tatsuya Chikaraishi; Kenjiro Kimura
Journal:  Clin Exp Nephrol       Date:  2011-04-19       Impact factor: 2.801

5.  Inhibitor of differentiation 3, a transcription factor, regulates hyperlipidemia-associated kidney disease.

Authors:  Dominika Nackiewicz; Paromita Dey; Barbara Szczerba; Saleh Mohammad; Jennifer L Kaplan; Coleen A McNamara; Umesh S Deshmukh; Harini Bagavant
Journal:  Nephron Exp Nephrol       Date:  2014-05-16

6.  Eight weeks of dietary overfeeding increases renal filtration rates in humans: implications for the pathogenesis of diabetic hyperfiltration.

Authors:  J D Covington; G A Bray; L M Redman; D L Johannsen; E Ravussin
Journal:  J Intern Med       Date:  2015-06-15       Impact factor: 8.989

7.  Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.

Authors:  James M Szymanski; Meryl Waldman; Cathy Conry-Cantilena; Kamille Aisha West
Journal:  J Clin Apher       Date:  2018-12-10       Impact factor: 2.821

Review 8.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

9.  Longitudinal lipid trends and adverse outcomes in patients with CKD: a 13-year observational cohort study.

Authors:  Ching-Wei Tsai; Han-Chun Huang; Hsiu-Yin Chiang; Chih-Wei Chung; Shih-Ni Chang; Pei-Lun Chu; Chin-Chi Kuo
Journal:  J Lipid Res       Date:  2019-01-14       Impact factor: 5.922

10.  Disorders of lipid metabolism and chronic kidney disease in the elderly.

Authors:  Devasmita Choudhury; Meryem Tuncel; Moshe Levi
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.